Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

Details for Australian Patent Application No. 2009256584 (hide)

Owner Astex Therapeutics Limited

Inventors Freyne, Eddy Jean Edgard; Woodhead, Andrew James; Carr, Maria Grazia; Saxty, Gordon; Benning, Rajdeep Kaur; Woodhead, Steven John; Madin, Andrew; Angibaud, Patrick Rene; Congreve, Miles Stuart; Frederickson, Martyn; Vickerstaffe, Emma; Berdini, Valerio; Murray, Christopher William; Hamlett, Christopher Charles Frederick; Govaerts, Tom Cornelis Hortense; Griffiths-Jones, Charlotte Mary; Williams, Brian, John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009256584

PCT Pub. Number WO2009/150240

Priority 61/061,184 13.06.08 US; 0810902.7 13.06.08 GB

Filing date 12 June 2009

Wipo publication date 17 December 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2009/150240 Priority application(s): WO2009/150240

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256585-EIF2 gamma gene as a diagnostic target for the identification of fungal and yeast species

2009256574-2,4'-bipyridinyl compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer